HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model.

Abstract
A significant increase in the incidence of pertussis in adolescents and adults has been observed in vaccinated populations. Concomitantly, emergence of novel pertussis toxin and pertactin types in circulating Bordetella pertussis isolates was noticed. In this study, immunity induced by acellular vaccines against infection due to isolates expressing different pertactin types and fimbriae was monitored in a mouse model. In accordance with previous studies, the effect of a bicomponent DTPa vaccine on bacterial clearance was lower when compared with tri- or pentavalent DTPa vaccines. Whatever the isolates used to infect mice, the tri- or pentavalent DTPa vaccines were both efficacious in inducing immunity that resulted in clearance of infection. These findings suggest that re-emergence of pertussis might not be related to emergence of isolates escaping vaccine protection. The present study reduces potential concerns about acellular vaccine efficacy, but frequent monitoring of protection and surveillance of the evolution of the B. pertussis population remains of particular importance.
AuthorsPhilippe Denoël, Fabrice Godfroid, Nicole Guiso, Hans Hallander, Jan Poolman
JournalVaccine (Vaccine) Vol. 23 Issue 46-47 Pg. 5333-41 (Nov 16 2005) ISSN: 0264-410X [Print] Netherlands
PMID16054273 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Pertussis Vaccine
  • Vaccines, Acellular
Topics
  • Animals
  • Bordetella pertussis (immunology)
  • Colony Count, Microbial
  • Female
  • Humans
  • Lung (microbiology)
  • Mice
  • Mice, Inbred BALB C
  • Pertussis Vaccine (chemistry, immunology)
  • Reproducibility of Results
  • Species Specificity
  • Vaccines, Acellular (chemistry, immunology)
  • Whooping Cough (microbiology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: